생물유전자원의 거래유형 및 이익공유 사례 연구

Domestic bio companies mainly use foreign genetic resources. However, after the Nagoya Protocol came into force, there were issues that bio companies should be aware of when using overseas genetic resources. In order for bio companies to take a look at such precautions in advance, they need to know which type of genetic resource is most suitable for trading. Accordingly, this paper has subdivided the transaction types of genetic resources based on the approach to genetic resources. Through this type of genetic resource transaction, bio companies should select the transaction type that has the fastest and simplest access permit process. This will help reduce unnecessary administrative costs for bio companies and ultimately enhance international competitiveness. In addition, this paper examines cases of profit-sharing of overseas genetic resources by domestic users and cases of profit-sharing by domestic users of genetic resources in Korea. As a result, the following implications were drawn. First, it is necessary for domestic users to secure overseas genetic resources and support for technology development. Second, the commercial use of domestic genetic resources by overseas users should be encouraged. Third, domestic users should be encouraged to secure domestic genetic resources.